Naglazyme and hypertension Patient Reports February 10, 2010

Naglazyme Side Effects Report #5615549-3
Naglazyme side effect was reported by a Physician from GERMANY on Jan 17, 2008. Female patient, child 9 years of age, weighting 44.09 lb, was diagnosed with mucopolysaccharidosis vi and was treated with Naglazyme. After drug was administered, patient experienced the following side effects: anaphylactic reaction, anaphylactoid reaction, cough, hypersensitivity, hypertension, infusion related reaction. Naglazyme dosage: 5MG; IV, 15 MG; IV. During the same period patient was treated with DIMETINDENE MALEATE, PREDNISOLONE, RANITIDINE. Patient was hospitalized. Patient recovered.

Naglazyme Side Effects Report #5397131-9
Naglazyme side effect was reported by a Health Professional from UNITED STATES on July 06, 2007. Female patient, child 7 years of age, weighting 46.96 lb, was diagnosed with mucopolysaccharidosis vi and was treated with Naglazyme. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, carpal tunnel syndrome , disease recurrence, gastrointestinal haemorrhage, hypertension, infusion related reaction, mastoiditis, rash erythematous, trigger finger. Naglazyme dosage: 1 MG/KG; QW; IV. During the same period patient was treated with METHYLPHENIDATE, PREDNISONE, LANSOPRAZOLE, CALCIUM CARBONATE, DIPHENHYDRAMINE, CLONIDINE, HYDROCORTISONE SUCCINATE. Patient was hospitalized. Patient recovered.

Naglazyme Side Effects Report #5926209-3
Naglazyme side effect was reported by a Physician from UNITED STATES on Oct 02, 2008. Female patient, child 7 years of age, weighting 46.96 lb, was diagnosed with mucopolysaccharidosis vi, attention deficit/hyperactivity disorder and was treated with Naglazyme. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, bone marrow transplant , gastrointestinal haemorrhage, hypertension, infusion related reaction, international normalised ratio abnormal, mastoiditis, urticaria. Naglazyme dosage: 1 MG/KG; QW; IVDRP. During the same period patient was treated with METHYLPHENIDATE, PREDNISONE, LANSOPRAZOLE, CALCIUM CARBONATE, DIPHENHYDRAMINE, HYDROCORTISONE SUCCINATE. Patient was hospitalized. Patient recovered.

Naglazyme Side Effects Report #6017314-4
Naglazyme side effect was reported by a Consumer or non-health professional from BRAZIL on Dec 04, 2008. Male patient, child 4 years of age, weighting 35.27 lb, was diagnosed with mucopolysaccharidosis vi and was treated with Naglazyme. After drug was administered, patient experienced the following side effects: chest pain , hypertension, infusion related reaction, lethargy. Naglazyme dosage: 15 MG;QW; IVDRP. During the same period patient was treated with FLEBOCORTID, ACETAMINOPHEN. Patient recovered.


Naglazyme Side Effects Report #6106778-3
Naglazyme side effect was reported by a Physician from BRAZIL on Feb 17, 2009. Male patient, child 3 years of age, weighting 35.27 lb, was diagnosed with mucopolysaccharidosis vi and was treated with Naglazyme. After drug was administered, patient experienced the following side effects: chest pain , hypertension, infusion related reaction, lethargy. Naglazyme dosage: 15 MG QW IV DRP. During the same period patient was treated with FLEBOCORTID, ACETAMINOPHEN. Patient recovered.

Naglazyme Side Effects Report #5594001-8
Naglazyme side effect was reported by a Physician from GERMANY on Jan 02, 2008. Female patient, 19 years of age, weighting 44.09 lb, was diagnosed with mucopolysaccharidosis vi and was treated with Naglazyme. After drug was administered, patient experienced the following side effects: hypersensitivity, hypertension, rash , urticaria. Naglazyme dosage: 5 MG;IV. Patient recovered.